SSB 1138 (LSB 1939XC (3) 91)

SENATE FILE _____ 

BY  (PROPOSED COMMITTEE ON HEALTH AND HUMAN SERVICES BILL BY CHAIRPERSON KLIMESH)

A BILL FOR

An Act relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for public employees.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:

    Section 1.  ANTI-OBESITY MEDICATION REVIEW AND REPORT.  For purposes of the medical assistance program under chapter 249A and health insurance plans established pursuant to chapter 509A for public employees, the department of health and human services and the department of administrative services shall review anti-obesity medications, including GLP-1 agonists, for effectiveness relating to weight loss, the impact on comorbidities, the potential for cost savings due to deferred medical procedures and reduced medications related to comorbidity, recommended eligibility requirements, and any other criteria the departments deem relevant. The department of health and human services and the department of administrative services shall submit a report to the general assembly by January 5, 2026, with the departments’ findings and proposed eligibility requirements.
EXPLANATION
The inclusion of this explanation does not constitute agreement with
the explanation’s substance by the members of the general assembly.
   This bill relates to the department of health and human services (HHS) and the department of administrative services (DAS) review of anti-obesity medication for purposes of the medical assistance program and health insurance plans established pursuant to Code chapter 509A for public employees.
   The bill requires HHS and DAS to review anti-obesity medications, including GLP-1 agonists, for effectiveness, comorbidities, cost savings, and eligibility requirements as described in the bill. HHS and DAS shall submit a report to the general assembly by January 5, 2026, containing HHS’s and DAS’s findings and proposed eligibility requirements.